Search Results

WHO GUIDELINE ON BIOPHARMACEUTICS CLASSIFICATION SYSTEM -BASED BIOWAIVERS.

Subjects: WORLD Health Organization; DRUG delivery systems; COMBINATION drug therapy

• Source: WHO Drug Information. 2023, Vol. 37 Issue 3, p670-693. 24p.

Record details

WHO Biowaiver Project - Preparation for cycle IV (2021): Prioritization exercise of active pharmaceutical ingredients on the WHO Model List of Essential Medicines for solubility determination and Biopharmaceutics Classification System-based classification.

Subjects: CHLOROQUINE; DOSAGE forms of drugs; EMERGENCY medical services

• Source: WHO Drug Information. 2020, Vol. 34 Issue 3, p485-491. 7p.

Record details

WHO BIOWAIVER PROJECT - PREPARATION FOR CYCLE V (2022): PRIORITIZATION EXERCISE OF ACTIVE PHARMACEUTICAL INGREDIENTS ON THE WHO MODEL LIST OF ESSENTIAL MEDICINES FOR SOLUBILITY DETERMINATION AND BIOPHARMACEUTICS CLASSIFICATION SYSTEM-BASED CLASSIFICATION.

Subjects: WORLD Health Organization; ESSENTIAL drugs; PUBLIC health

• Source: WHO Drug Information. 2021, Vol. 35 Issue 3, p606-611. 6p.

Record details

Evaluation of changes in oral drug absorption in preterm and term neonates for Biopharmaceutics Classification System (BCS) class I and II compounds.

• Authors : Somani, Amit A.; Thelen, Kirstin; Zheng, Songmao

Subjects: DRUG absorption; DRUG therapy; BIOPHARMACEUTICS

• Source: British Journal of Clinical Pharmacology. Jan2016, Vol. 81 Issue 1, p137-147. 11p.

Record details

Biopharmaceutical optimization in neglected diseases for paediatric patients by applying the provisional paediatric biopharmaceutical classification system.

• Authors : del Moral Sanchez, Jose Manuel; Gonzalez‐Alvarez, Isabel; Cerda‐Revert, Aaron

Subjects: CHILD patients; BIOPHARMACEUTICS; BIOPHARMACEUTICAL research

• Source: British Journal of Clinical Pharmacology. Oct2018, Vol. 84 Issue 10, p2231-2241. 11p. 1 Diagram, 5 Charts.

Record details

Adverse immunostimulation caused by impurities: The dark side of biopharmaceuticals.

• Authors : Reijers, Joannes A. A. (AUTHOR); Malone, Karen E. (AUTHOR); Bajramovic, Jeffrey J. (AUTHOR)

Subjects: ENDOTOXINS; DRUG side effects; BIOPHARMACEUTICS

• Source: British Journal of Clinical Pharmacology. Jul2019, Vol. 85 Issue 7, p1418-1426. 9p. 3 Charts.

Record details

Population pharmacokinetic analysis of RO5459072, a low water‐soluble drug exhibiting complex food–drug interactions.

• Authors : Kratochwil, Nicole A. (AUTHOR); Stillhart, Cordula (AUTHOR); Diack, Cheikh (AUTHOR)

Subjects: DRUG-food interactions; PHARMACOKINETICS; BIOPHARMACEUTICS

• Source: British Journal of Clinical Pharmacology. Sep2021, Vol. 87 Issue 9, p3550-3560. 11p.

Record details

Considerations for application of biopharmaceutics classification system in chicken: Exemplified by seven drugs classification.

• Authors : Liu, Yang (AUTHOR); Li, Xiangxiu (AUTHOR); Zhang, Yujuan (AUTHOR)

Subjects: DRUG solubility; ATP-binding cassette transporters; CHICKENS

• Source: Journal of Veterinary Pharmacology & Therapeutics. Mar2020, Vol. 43 Issue 2, p179-188. 10p.

Record details

Bioengineered molecules for the management of haemophilia: Promise and remaining challenges.

• Authors : Pipe, S. W.

Subjects: HEMORRHAGE treatment; GENE therapy; MUTAGENESIS

• Source: Haemophilia. May2018 Supplement S6, Vol. 24, p68-75. 8p. 2 Charts.

Record details

Cell-specific biomarkers and targeted biopharmaceuticals for breast cancer treatment.

• Authors : Liu, Mei; Li, Zhiyang; Yang, Jingjing

Subjects: BIOMARKERS; BIOPHARMACEUTICS; TARGETED drug delivery

• Source: Cell Proliferation. Aug2016, Vol. 49 Issue 4, p409-420. 12p.

Record details